Your institution may have access to this item. Find your institution then sign in to continue.
Title
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.
Authors
Kamm, M A; Hanauer, S B; Panaccione, R; Colombel, J-F; Sandborn, W J; Pollack, P F; Zhou, Q; Robinson, A M
Abstract
Treatments that achieve sustainable steroid-free clinical remission in Crohn's disease are needed; however, long-term steroid-sparing efficacy data are limited.